Methotrexate

Methotrexate was originally developed in the 1940s as a cancer chemotherapy agent but is now used far more commonly at low doses for autoimmune and inflammatory conditions ^[1][2]. Its mechanisms differ significantly depending on the dose.

In cancer (high-dose): Methotrexate competitively inhibits dihydrofolate reductase (DHFR), the enzyme that converts dihydrofolate to tetrahydrofolate ^[1]. Tetrahydrofolate is essential for the synthesis of purines and thymidylate, which are building blocks for DNA. By blocking this pathway, methotrexate prevents cancer cells from replicating their DNA and dividing ^[2].

In autoimmune disease (low-dose): At the weekly doses used for rheumatoid arthritis (7.5-25 mg/week), the anti-inflammatory mechanism is thought to be primarily mediated through adenosine release rather than folate antagonism ^[3]. Methotrexate causes intracellular accumulation of AICAR (aminoimidazole carboxamide ribonucleotide), which promotes the release of adenosine — a potent endogenous anti-inflammatory molecule. Adenosine reduces neutrophil adhesion, inhibits pro-inflammatory cytokine production (TNF-alpha, IL-6, IL-8), and suppresses T-cell activation ^[3][4].

Methotrexate also inhibits enzymes involved in polyamine synthesis and suppresses the production of reactive oxygen species by neutrophils ^[4]. These multiple anti-inflammatory mechanisms explain why methotrexate remains the most effective conventional DMARD for rheumatoid arthritis, with ACR response rates of 50-65% ^[5].

Methotrexate for rheumatoid arthritis is taken once weekly — NOT daily. This is a critical safety point, as accidental daily dosing has caused fatal toxicity ^[1].

Therapeutic benefit typically takes 4-8 weeks to become apparent, with maximum improvement at 3-6 months. Expect your rheumatologist to start at a low dose (7.5-15 mg/week) and gradually increase as needed ^[5].

You will be prescribed folic acid (1 mg daily or 5 mg weekly) to take alongside methotrexate, which significantly reduces side effects — particularly mouth sores, nausea, and liver enzyme elevations — without reducing efficacy ^[6].

Expect regular blood monitoring: complete blood count (CBC) and liver function tests every 4-8 weeks initially, then every 8-12 weeks once stable. This is non-negotiable for safe methotrexate use ^[1].

The most common side effects during the first weeks are nausea, fatigue, and mouth sores. Nausea often occurs the day of or day after dosing ("methotrexate hangover"). Splitting the dose, taking it at bedtime, or switching to subcutaneous injection can help ^[5].

Alcohol: Alcohol is strongly discouraged during methotrexate therapy ^[1]. Both methotrexate and alcohol are hepatotoxic, and their combination significantly increases the risk of liver fibrosis and cirrhosis. Most rheumatology guidelines recommend limiting alcohol to no more than 2 standard drinks per week, with many experts advising complete abstinence ^[5]. Alcohol intake should be discussed at every rheumatology visit.

Food: Methotrexate can be taken with or without food ^[1]. Taking it with food may reduce nausea. Some patients find taking their weekly dose at bedtime with food reduces the "methotrexate hangover" the next day.

Folic Acid Supplements: Folic acid (1 mg daily or 5 mg weekly, taken on a day other than the methotrexate day) is standard co-therapy and significantly reduces GI, mucosal, and hepatic side effects ^[6]. Do not take folic acid on the same day as methotrexate, as theoretical concerns exist about reduced efficacy.

Caffeine: Some small studies suggest high caffeine intake may reduce methotrexate efficacy for RA by antagonizing adenosine, the proposed mediator of its anti-inflammatory effect ^[3]. Evidence is inconclusive, but moderate caffeine consumption is reasonable.

Rheumatoid Arthritis: Start at 7.5-15 mg orally ONCE WEEKLY; increase by 2.5-5 mg every 2-4 weeks to a maximum of 25 mg/week ^[1][5]. Most patients achieve optimal response at 15-20 mg/week.

Psoriasis: Start at 7.5-15 mg ONCE WEEKLY (single dose or split into 3 doses 12 hours apart over 24 hours). Maximum 25-30 mg/week ^[1].

Ectopic Pregnancy: 50 mg/m2 intramuscularly as a single dose (medical management protocol) ^[7].

Oncologic Dosing: Varies widely by cancer type and protocol (50 mg/m2 to 12,000+ mg/m2). High-dose protocols require leucovorin rescue.

Subcutaneous Administration: Otrexup and Rasuvo auto-injectors (7.5-25 mg) provide more consistent absorption than oral, especially at doses >15 mg/week.

Mandatory Monitoring: - CBC with differential and platelets: baseline, every 2-4 weeks for 3 months, then every 8-12 weeks - Liver function tests: same schedule as CBC - Serum creatinine: baseline and periodically - Hepatitis B and C serologies: before starting - Chest X-ray: before starting

CRITICAL: This is a WEEKLY medication for autoimmune disease. NEVER take daily.

Generic methotrexate tablets are very affordable — a 4-week supply of 15 mg/week costs approximately $10-20 at most pharmacies ^[8].

Cost-saving strategies: - Generic tablets: Methotrexate 2.5 mg tablets are inexpensive. Most pharmacies charge $10-15 for a monthly supply - Oral vs. injectable: The oral tablets are the least expensive option. However, if injection is needed, generic prefilled syringes are available at $30-60/month vs. $500+ for brand-name Otrexup or Rasuvo auto-injectors - $4 generic lists: Methotrexate tablets are included on many pharmacy discount programs - GoodRx coupons: Can reduce costs to $8-12 for oral tablets - Specialty pharmacy for injectables: If subcutaneous injections are needed, specialty pharmacies may offer better pricing on generic prefilled syringes - Folic acid is cheap: Generic folic acid 1 mg costs $3-5 for a 90-day supply - Patient assistance: Manufacturer programs available for brand-name auto-injectors (Otrexup, Rasuvo) for uninsured patients

Pregnancy (Category X): Methotrexate is absolutely contraindicated in pregnancy for non-neoplastic diseases ^[1]. It is a known teratogen causing a pattern of congenital anomalies known as "methotrexate embryopathy" (limb defects, craniofacial abnormalities, growth restriction) and can cause spontaneous abortion. In fact, methotrexate is used therapeutically to treat ectopic pregnancy.

Pregnancy Prevention: Women of childbearing potential must have a negative pregnancy test before starting methotrexate and must use effective contraception during therapy and for at least one ovulatory cycle (one menstrual period) after the last dose ^[1]. Men should use contraception during therapy and for at least 3 months after stopping, due to potential effects on spermatogenesis.

Breastfeeding: Methotrexate is contraindicated during breastfeeding ^[1]. It is excreted in breast milk and can cause serious adverse effects in nursing infants, including immunosuppression and bone marrow toxicity.

Fertility: Methotrexate can cause reversible oligospermia in men and menstrual irregularities in women. Fertility typically recovers after drug discontinuation ^[1].

Generic methotrexate tablets (2.5 mg) have been available for decades and are manufactured by multiple companies. Brand-name Trexall (5 mg, 7.5 mg, 10 mg, 15 mg tablets) is available but rarely prescribed due to the cost difference.

For subcutaneous injection, the landscape is more complex: - Generic prefilled syringes are available and significantly cheaper - Otrexup and Rasuvo are brand-name auto-injectors that offer convenience but at much higher cost ($500-2,000/month) - Xatmep is a brand-name oral solution for patients who cannot swallow tablets

For most patients, generic 2.5 mg tablets (taken as multiple tablets weekly to reach the prescribed dose) remain the most cost-effective option with no difference in efficacy.